Navigation Links
Denmark joins the Nordic EMBL Partnership for Molecular Medicine
Date:3/5/2013

Today, the Nordic EMBL Partnership for Molecular Medicine celebrates two important milestones: the renewal of the partnership agreement for an extended period of 10 years, and the expansion of the Nordic EMBL network with the official opening of the Danish Research Institute of Translational Neuroscience (DANDRITE) at Aarhus University, which will become its Danish node.

The Nordic EMBL Partnership for Molecular Medicine was initiated in 2007 between the University of Oslo, Ume University, University of Helsinki and EMBL. As a result, three nodes were established in Norway, Sweden and Finland, each of which complements the research expertise of the other partners and, working closely with EMBL, aims to rise to challenges in biomedicine and to foster industry collaborations. In the five years since the launch of the partnership, the network has emerged as a strategic player in the molecular understanding of disease mechanisms in Europe, its impact and success recognised with today's signing of a renewed partnership agreement for an extended period of 10 years.

The research alliance is further strengthened by the growth of the partnership through the creation and inauguration of a Danish node. Complementing the research profile of the three existing nodes, DANDRITE will focus on conducting state-of-the-art research in the field of neuroscience. "We're excited to welcome Denmark as the fourth partner in the Nordic EMBL Partnership for Molecular Medicine. In a competitive national process, Aarhus University was selected to host the Danish node. The decision was made on the basis of the university's scientific expertise in the neurosciences and its research environment, which offer an excellent base for building a world-class collaborative institute like DANDRITE," says Iain Mattaj, Director General of EMBL.

The establishment of the Danish node was made possible through the Lundbeck Foundation, one of the largest private contributors to natural science research in Denmark, which funds the new centre jointly with Aarhus University. "The partnership with EMBL has arisen from the independent research approach, and DANDRITE has high ambitions, plenty of funding, independence and excellent infrastructure. Our ambition is to be the first with the latest ideas, rather than having to stand on the shoulders of others," says Poul Nissen, Director of DANDRITE and Professor of Protein Biochemistry at Aarhus University.

DANDRITE joins the Institute for Molecular Medicine Finland (FIMM, University of Helsinki), Centre for Molecular Medicine Norway (NCMM, University of Oslo), the Laboratory for Molecular Infection Medicine Sweden (MIMS, Ume University) and EMBL. All nodes benefit from continuous scientific and administrative support from EMBL, as well as from adopting aspects of the EMBL operational model, such as international recruitment, staff-turnover and the external review system.


'/>"/>

Contact: Lena Raditsch
lena.raditsch@embl.de
49-062-213-878-125
European Molecular Biology Laboratory
Source:Eurekalert  

Related biology news :

1. Denmark can triple its biomass production and improve the environment
2. Warren Lammert Joins IntelliMedix Board of Advisors
3. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
4. Book shows evolution that joins human and environmental sciences
5. Brazil joins global initiative for biodiversity data access
6. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
7. Brazil joins international marine research effort
8. Steve Fisher joins American Health IT LLC as VP of Operations
9. Flavor and the new Nordic cuisine: BioMed Centrals new scientific journal Flavor is launched
10. New grants to innovation corps nodes further enhance public-private partnership
11. CHOP and BGI strengthen partnership with agreement on pediatric brain tumor collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Denmark joins the Nordic EMBL Partnership for Molecular Medicine
(Date:8/15/2017)... LLC , a medical device company focused on improving the safety ... ISO 13485 Certification, the global standard for medical device quality management ... ... for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates our ...
(Date:7/20/2017)... Delta (NYSE: DAL ) customers now can use ... Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington ... Delta,s biometric boarding pass experience that ... integrated into the boarding process to allow eligible Delta SkyMiles Members who ...
(Date:6/30/2017)... Today, American Trucking Associations announced Seeing ... and eye tracking software, became the newest member ... "Artificial intelligence and advanced sensing algorithms ... driver,s attentiveness levels while on the road.  Drivers ... fatigue and prevent potential accidents, which could lead ...
Breaking Biology News(10 mins):
(Date:8/22/2017)... ... 2017 , ... Cutting Edge Spine , a technology-driven ... implant technologies, announced today the appointment of Luke Maher as Director U.S. Sales. ... to directing Cutting Edge Spine’s national sales force, including 12+ years at Medtronic ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... in pain management is the practice of opioid-dose sparing. Opioid-dose sparing refers to ... shown promising results, including with non-steroidal anti-inflammatory drugs (NSAIDs). , The potential for ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... ... service pipeline built upon patented KBioBox technology, the extended GUIDE-Seq ananlysis. KBioBox has ... GUIDE-Seq computation pipeline to be provide scientists with easy to understand reports, extended ...
(Date:8/21/2017)... , ... August 20, 2017 , ... ... of Biomedical Optics (JBO) starting 1 January 2018. The journal is published by ... Optics publishes papers on the use of modern optical technology for improved health ...
Breaking Biology Technology: